R emember: Always consult with your healthcare provider before making any significant changes to your diet or exercise routine while taking GLP-1 medications.
doi:10.1038/s41598-021-03670-5
Include when each symptom began, whether it occurs daily and what seems to improve or worsen it
E-values were calculated to quantify robustness to unmeasured confounding
News provided by American Diabetes Association Jun 29, 2021, 09:30 ET WASHINGTON, June 29, 2021 /PRNewswire/ -- Data from the SURPASS global clinical development program for Eli Lilly and Company's tirzepatide, a novel investigational once-weekly medication for the treatment of type 2 diabetes, demonstrates statistically significant A1C and weight reductions versus several comparators
These changes can lead to clumps or strands that cast shadows on the retina, resulting in floaters or myodesopsias